Phase II trial of erlotinib plus sirolimus for recurrent glioblastoma multiforme (GBM)

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Friedman, HS; Desjardins, A; Vredenburgh, JJ; Rich, JN; Sathornsumetee, S; Gururangan, S; Quinn, JA; Reardon, DA

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 2062 - 2062

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.2062

Language

  • en